{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:03:22Z","timestamp":1783767802621,"version":"3.55.0"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Protocolos de investigaci\u00f3n multidisciplinarios de Cohorte de Largo Aliento sobre Temas Prioritarios en el IMSS 2023","award":["R-2020-785-154"],"award-info":[{"award-number":["R-2020-785-154"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04253-y","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T12:13:55Z","timestamp":1774440835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Is cancer the result of uncontrolled cellular growth? a glance into the tumorigenic process"],"prefix":"10.1186","volume":"26","author":[{"given":"Rosario","family":"Castro-Oropeza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonieta","family":"Ch\u00e1vez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Mantilla-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha E.","family":"Ruiz-Tachiqu\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Mayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pi\u00f1a-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"4253_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"4253_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"4253_CR3","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S1470-2045(12)70211-5","volume":"13","author":"F Bray","year":"2012","unstructured":"Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008\u20132030): a population-based study. Lancet Oncol. 2012;13:790\u2013801. https:\/\/doi.org\/10.1016\/S1470-2045(12)70211-5.","journal-title":"Lancet Oncol"},{"key":"4253_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/CEJ.0000000000000594","volume":"29","author":"C Santucci","year":"2020","unstructured":"Santucci C, Carioli G, Bertuccio P, Malvezzi M, Pastorino U, Boffetta P, et al. Progress in cancer mortality, incidence, and survival: a global overview. Eur J Cancer Prev. 2020;29:367\u201381. https:\/\/doi.org\/10.1097\/CEJ.0000000000000594.","journal-title":"Eur J Cancer Prev"},{"key":"4253_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/10732748211038735","author":"P Pi\u00f1a-S\u00e1nchez","year":"2021","unstructured":"Pi\u00f1a-S\u00e1nchez P, Ch\u00e1vez-Gonz\u00e1lez A, Ruiz-Tachiqu\u00edn M, Vadillo E, Monroy-Garc\u00eda A, Montesinos JJ, et al. Cancer biology, epidemiology, and treatment in the 21st century: current status and future challenges from a biomedical perspective. Cancer Control. 2021. https:\/\/doi.org\/10.1177\/10732748211038735.","journal-title":"Cancer Control"},{"key":"4253_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"4253_CR7","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nm1087","volume":"10","author":"B Vogelstein","year":"2004","unstructured":"Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789\u201399. https:\/\/doi.org\/10.1038\/nm1087.","journal-title":"Nat Med"},{"key":"4253_CR8","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.arcmed.2022.11.003","volume":"53","author":"F Recillas-Targa","year":"2022","unstructured":"Recillas-Targa F. Cancer epigenetics: an overview. Arch Med Res. 2022;53:732\u201340. https:\/\/doi.org\/10.1016\/j.arcmed.2022.11.003.","journal-title":"Arch Med Res"},{"key":"4253_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.886613","author":"R Castro-Oropeza","year":"2022","unstructured":"Castro-Oropeza R, Pi\u00f1a-S\u00e1nchez P. Epigenetic and transcriptomic regulation landscape in HPV+ cancers: biological and clinical implications. Front Genet. 2022. https:\/\/doi.org\/10.3389\/fgene.2022.886613.","journal-title":"Front Genet"},{"key":"4253_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2012.1701","volume":"42","author":"V Conteduca","year":"2013","unstructured":"Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco F. H. pylori infection and gastric cancer: state of the art. Int J Oncol. 2013;42:5\u201318. https:\/\/doi.org\/10.3892\/ijo.2012.1701.","journal-title":"Int J Oncol"},{"key":"4253_CR11","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1042\/BST20180519","volume":"46","author":"JL Barnes","year":"2018","unstructured":"Barnes JL, Zubair M, John K, Poirier MC, Martin FL. Carcinogens and DNA damage. Biochem Soc Trans. 2018;46:1213\u201324. https:\/\/doi.org\/10.1042\/BST20180519.","journal-title":"Biochem Soc Trans"},{"key":"4253_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1582-4934.2000.tb00113.x","volume":"4","author":"NC Popescu","year":"2000","unstructured":"Popescu NC. Comprehensive genetic analysis of cancer cells. J Cell Mol Med. 2000;4:151\u201363. https:\/\/doi.org\/10.1111\/j.1582-4934.2000.tb00113.x.","journal-title":"J Cell Mol Med"},{"key":"4253_CR13","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2024.14311","volume":"27","author":"V Larios-Serrato","year":"2024","unstructured":"Larios-Serrato V, Valdez-Salazar H-A, Ruiz-Tachiqu\u00edn M-E. The landscape of 8q24 cytoband in gastric cancer (Review). Oncol Lett. 2024;27:179. https:\/\/doi.org\/10.3892\/ol.2024.14311.","journal-title":"Oncol Lett"},{"key":"4253_CR14","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546\u201358. https:\/\/doi.org\/10.1126\/science.1235122.","journal-title":"Science"},{"key":"4253_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.582","author":"TC Dakal","year":"2024","unstructured":"Dakal TC, Dhabhai B, Pant A, Moar K, Chaudhary K, Yadav V, et al. Oncogenes and tumor suppressor genes: functions and roles in cancers. MedComm. 2024. https:\/\/doi.org\/10.1002\/mco2.582.","journal-title":"MedComm"},{"key":"4253_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/sqb.2005.70.039","volume":"70","author":"H Varmus","year":"2005","unstructured":"Varmus H, Pao W, Politi K, Podsypanina K, Du Y-C. Oncogenes come of age. Cold Spring Harb Symp Quant Biol. 2005;70:1\u20139. https:\/\/doi.org\/10.1101\/sqb.2005.70.039.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"4253_CR17","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1101\/gad.282145.116","volume":"30","author":"NJ Dyson","year":"2016","unstructured":"Dyson NJ. RB1: a prototype tumor suppressor and an enigma. Genes Dev. 2016;30:1492\u2013502. https:\/\/doi.org\/10.1101\/gad.282145.116.","journal-title":"Genes Dev"},{"key":"4253_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature01408","volume":"421","author":"EC Friedberg","year":"2003","unstructured":"Friedberg EC. DNA damage and repair. Nature. 2003;421:436\u201340. https:\/\/doi.org\/10.1038\/nature01408.","journal-title":"Nature"},{"key":"4253_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23319-1","volume":"12","author":"Y-J Kang","year":"2022","unstructured":"Kang Y-J, O\u2019Haire S, Franchini F, IJzerman M, Zalcberg J, Macrae F, et al. A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours. Sci Rep. 2022;12:20495. https:\/\/doi.org\/10.1038\/s41598-022-23319-1.","journal-title":"Sci Rep"},{"key":"4253_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03538-4","volume":"24","author":"M Ahmed","year":"2024","unstructured":"Ahmed M, Kim DR. Life history dynamics of evolving tumors: insights into task specialization, trade-offs, and tumor heterogeneity. Cancer Cell Int. 2024;24:364. https:\/\/doi.org\/10.1186\/s12935-024-03538-4.","journal-title":"Cancer Cell Int"},{"key":"4253_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13195-1","volume":"10","author":"J Hausser","year":"2019","unstructured":"Hausser J, Szekely P, Bar N, Zimmer A, Sheftel H, Caldas C, et al. Tumor diversity and the trade-off between universal cancer tasks. Nat Commun. 2019;10:5423. https:\/\/doi.org\/10.1038\/s41467-019-13195-1.","journal-title":"Nat Commun"},{"key":"4253_CR22","first-page":"3075","volume":"51","author":"LA Loeb","year":"1991","unstructured":"Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 1991;51:3075\u20139.","journal-title":"Cancer Res"},{"key":"4253_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-0714-y","volume":"12","author":"JJ Adashek","year":"2020","unstructured":"Adashek JJ, Kato S, Lippman SM, Kurzrock R. The paradox of cancer genes in non-malignant conditions: implications for precision medicine. Genome Med. 2020;12:16. https:\/\/doi.org\/10.1186\/s13073-020-0714-y.","journal-title":"Genome Med"},{"key":"4253_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578:94\u2013101. https:\/\/doi.org\/10.1038\/s41586-020-1943-3.","journal-title":"Nature"},{"key":"4253_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N McGranahan","year":"2017","unstructured":"McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future. Cell. 2017;168:613\u201328. https:\/\/doi.org\/10.1016\/j.cell.2017.01.018.","journal-title":"Cell"},{"key":"4253_CR26","doi-asserted-by":"publisher","unstructured":"Seed G, Truong F, Riahi R, O\u2019Leary B. Tumor Evolution Driving Genome Instability, Immune Interactions, and Response to Radiotherapy. Cancer J. 2025;31. https:\/\/doi.org\/10.1097\/PPO.0000000000000777.","DOI":"10.1097\/PPO.0000000000000777"},{"key":"4253_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.trecan.2023.05.004","volume":"9","author":"K Takahashi","year":"2023","unstructured":"Takahashi K, Tanaka T. Clonal evolution and hierarchy in myeloid malignancies. Trends Cancer. 2023;9:707\u201315. https:\/\/doi.org\/10.1016\/j.trecan.2023.05.004.","journal-title":"Trends Cancer"},{"key":"4253_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16132488","volume":"16","author":"M Wang","year":"2024","unstructured":"Wang M, Xie Y, Liu J, Li A, Chen L, Stromberg A, et al. A probabilistic approach to estimate the temporal order of pathway mutations accounting for intra-tumor heterogeneity. Cancers (Basel). 2024;16:2488. https:\/\/doi.org\/10.3390\/cancers16132488.","journal-title":"Cancers (Basel)"},{"key":"4253_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf362","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Kang S, Dou R, Zhang W, Liu Y, Wu Y, et al. IMOP-cancer: identifying mutation order pairs impacting cancer phenotypes. Brief Bioinform. 2025. https:\/\/doi.org\/10.1093\/bib\/bbaf362.","journal-title":"Brief Bioinform"},{"key":"4253_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05601-4","author":"M Gerstung","year":"2023","unstructured":"Gerstung M, Jolly C, Leshchiner I, Dentro SC, Gonzalez S, Rosebrock D, et al. Author correction: the evolutionary history of 2,658 cancers. Nature. 2023. https:\/\/doi.org\/10.1038\/s41586-022-05601-4.","journal-title":"Nature"},{"key":"4253_CR31","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","volume":"79","author":"DC Hinshaw","year":"2019","unstructured":"Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79:4557\u201366. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3962.","journal-title":"Cancer Res"},{"key":"4253_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41588-019-0576-7","volume":"52","author":"I Cort\u00e9s-Ciriano","year":"2020","unstructured":"Cort\u00e9s-Ciriano I, Lee JJ-K, Xi R, Jain D, Jung YL, Yang L, et al. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat Genet. 2020;52:331\u201341. https:\/\/doi.org\/10.1038\/s41588-019-0576-7.","journal-title":"Nat Genet"},{"key":"4253_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-020-2698-6","volume":"587","author":"TBK Watkins","year":"2020","unstructured":"Watkins TBK, Lim EL, Petkovic M, Elizalde S, Birkbak NJ, Wilson GA, et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature. 2020;587:126\u201332. https:\/\/doi.org\/10.1038\/s41586-020-2698-6.","journal-title":"Nature"},{"key":"4253_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/genes13010101","volume":"13","author":"J Heng","year":"2021","unstructured":"Heng J, Heng HH. Genome chaos, information creation, and cancer emergence: searching for new frameworks on the 50th anniversary of the \u201cWar on Cancer.\u201d Genes. 2021;13:101. https:\/\/doi.org\/10.3390\/genes13010101.","journal-title":"Genes"},{"key":"4253_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.712931","author":"L Chen","year":"2021","unstructured":"Chen L, Zhou X, Zeng T, Pan X, Zhang Y-H, Huang T, et al. Recognizing pattern and rule of mutation signatures corresponding to cancer types. Front Cell Dev Biol. 2021. https:\/\/doi.org\/10.3389\/fcell.2021.712931.","journal-title":"Front Cell Dev Biol"},{"key":"4253_CR36","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrg.2016.13","volume":"17","author":"AP Feinberg","year":"2016","unstructured":"Feinberg AP, Koldobskiy MA, G\u00f6nd\u00f6r A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016;17:284\u201399. https:\/\/doi.org\/10.1038\/nrg.2016.13.","journal-title":"Nat Rev Genet"},{"key":"4253_CR37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth K, Bayraktar R, Ferracin M, Calin GA. Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet. 2024;25:211\u201332. https:\/\/doi.org\/10.1038\/s41576-023-00662-1.","journal-title":"Nat Rev Genet"},{"key":"4253_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215\u201333. https:\/\/doi.org\/10.1016\/j.cell.2009.01.002.","journal-title":"Cell"},{"key":"4253_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/path.2806","volume":"223","author":"TA Farazi","year":"2011","unstructured":"Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol. 2011;223:102\u201315. https:\/\/doi.org\/10.1002\/path.2806.","journal-title":"J Pathol"},{"key":"4253_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156871","volume":"11","author":"A Eyking","year":"2016","unstructured":"Eyking A, Reis H, Frank M, Gerken G, Schmid KW, Cario E. MiR-205 and MiR-373 are associated with aggressive human mucinous colorectal cancer. PLoS One. 2016;11:e0156871. https:\/\/doi.org\/10.1371\/journal.pone.0156871.","journal-title":"PLoS One"},{"key":"4253_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-469","volume":"13","author":"G Xu","year":"2013","unstructured":"Xu G, Zhang Y, Wei J, Jia W, Ge Z, Zhang Z, et al. MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3. BMC Cancer. 2013;13:469. https:\/\/doi.org\/10.1186\/1471-2407-13-469.","journal-title":"BMC Cancer"},{"key":"4253_CR42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/onc.2014.9","volume":"34","author":"S-Y Wen","year":"2015","unstructured":"Wen S-Y, Lin Y, Yu Y-Q, Cao S-J, Zhang R, Yang X-M, et al. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer. Oncogene. 2015;34:717\u201325. https:\/\/doi.org\/10.1038\/onc.2014.9.","journal-title":"Oncogene"},{"key":"4253_CR43","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1158\/1078-0432.CCR-13-1024","volume":"20","author":"K Jones","year":"2014","unstructured":"Jones K, Nourse JP, Keane C, Bhatnagar A, Gandhi MK. Plasma MicroRNA are disease response biomarkers in classical Hodgkin lymphoma. Clin Cancer Res. 2014;20:253\u201364. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1024.","journal-title":"Clin Cancer Res"},{"key":"4253_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2020.12087","volume":"20","author":"P Pi\u00f1a-S\u00e1nchez","year":"2020","unstructured":"Pi\u00f1a-S\u00e1nchez P, Valdez-Salazar H-A, Ruiz-Tachiqu\u00edn M-E. Circulating microRNAs and their role in the immune response in triple-negative breast cancer (Review). Oncol Lett. 2020;20:1\u20131. https:\/\/doi.org\/10.3892\/ol.2020.12087.","journal-title":"Oncol Lett"},{"key":"4253_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123709","volume":"12","author":"TM Grzywa","year":"2020","unstructured":"Grzywa TM, Klicka K, W\u0142odarski PK. Regulators at every step\u2014how microRNAs drive tumor cell invasiveness and metastasis. Cancers (Basel). 2020;12:3709. https:\/\/doi.org\/10.3390\/cancers12123709.","journal-title":"Cancers (Basel)"},{"key":"4253_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","volume":"81","author":"JL Rinn","year":"2012","unstructured":"Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81:145\u201366. https:\/\/doi.org\/10.1146\/annurev-biochem-051410-092902.","journal-title":"Annu Rev Biochem"},{"key":"4253_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1571873","author":"O Tellez-Jimenez","year":"2025","unstructured":"Tellez-Jimenez O, Ordaz-Ramos A, Fonseca-Monta\u00f1o MA, Vazquez-Santillan K. Long non-coding RNAs: key regulators of stemness in breast cancer. Front Cell Dev Biol. 2025. https:\/\/doi.org\/10.3389\/fcell.2025.1571873.","journal-title":"Front Cell Dev Biol"},{"key":"4253_CR48","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s13402-018-0406-4","volume-title":"Cellular Oncology","author":"R Castro-Oropeza","year":"2018","unstructured":"Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K. The emerging role of lncRNAs in the regulation of cancer stem cells. In: Cellular Oncology. Springer Netherlands; 2018. p. 585\u2013603. https:\/\/doi.org\/10.1007\/s13402-018-0406-4."},{"key":"4253_CR49","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1038\/bjc.2013.233","volume":"108","author":"SW Cheetham","year":"2013","unstructured":"Cheetham SW, Gruhl F, Mattick JS, Dinger ME. Long noncoding RNAs and the genetics of cancer. Br J Cancer. 2013;108:2419\u201325. https:\/\/doi.org\/10.1038\/bjc.2013.233.","journal-title":"Br J Cancer"},{"key":"4253_CR50","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4161\/rna.20481","volume":"9","author":"T Gutschner","year":"2012","unstructured":"Gutschner T, Diederichs S. The hallmarks of cancer. RNA Biol. 2012;9:703\u201319. https:\/\/doi.org\/10.4161\/rna.20481.","journal-title":"RNA Biol"},{"key":"4253_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2025.13528","volume":"31","author":"R Castro-Oropeza","year":"2025","unstructured":"Castro-Oropeza R, Velazquez-Velazquez C, Vazquez-Santillan K, Mantilla-Morales A, Ruiz Tachiquin M, Torres J, et al. Landscape of lncRNAs expressed in Mexican patients with triple-negative breast cancer. Mol Med Rep. 2025;31:1\u201321. https:\/\/doi.org\/10.3892\/mmr.2025.13528.","journal-title":"Mol Med Rep"},{"key":"4253_CR52","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1093\/bib\/bbz118","volume":"21","author":"S Bao","year":"2020","unstructured":"Bao S, Zhao H, Yuan J, Fan D, Zhang Z, Su J, et al. Computational identification of mutator-derived lncRNA signatures of genome instability for improving the clinical outcome of cancers: a case study in breast cancer. Brief Bioinform. 2020;21:1742\u201355. https:\/\/doi.org\/10.1093\/bib\/bbz118.","journal-title":"Brief Bioinform"},{"key":"4253_CR53","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrm3890","volume":"15","author":"P Tessarz","year":"2014","unstructured":"Tessarz P, Kouzarides T. Histone core modifications regulating nucleosome structure and dynamics. Nat Rev Mol Cell Biol. 2014;15:703\u20138. https:\/\/doi.org\/10.1038\/nrm3890.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4253_CR54","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41589-021-00764-z","volume":"17","author":"K Jain","year":"2021","unstructured":"Jain K, Strahl BD. Oncohistones: corruption at the core. Nat Chem Biol. 2021;17:370\u20131. https:\/\/doi.org\/10.1038\/s41589-021-00764-z.","journal-title":"Nat Chem Biol"},{"key":"4253_CR55","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41586-019-1038-1","volume":"567","author":"BA Nacev","year":"2019","unstructured":"Nacev BA, Feng L, Bagert JD, Lemiesz AE, Gao J, Soshnev AA, et al. The expanding landscape of \u2018oncohistone\u2019 mutations in human cancers. Nature. 2019;567:473\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1038-1.","journal-title":"Nature"},{"key":"4253_CR56","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/ng.2814","volume":"45","author":"S Behjati","year":"2013","unstructured":"Behjati S, Tarpey PS, Presneau N, Scheipl S, Pillay N, Van Loo P, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45:1479\u201382. https:\/\/doi.org\/10.1038\/ng.2814.","journal-title":"Nat Genet"},{"key":"4253_CR57","doi-asserted-by":"publisher","first-page":"12238","DOI":"10.1073\/pnas.1614120113","volume":"113","author":"S Zhao","year":"2016","unstructured":"Zhao S, Bellone S, Lopez S, Thakral D, Schwab C, English DP, et al. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial\u2013mesenchymal transition. Proc Natl Acad Sci U S A. 2016;113:12238\u201343. https:\/\/doi.org\/10.1073\/pnas.1614120113.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4253_CR58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.3757","volume":"49","author":"S Papillon-Cavanagh","year":"2017","unstructured":"Papillon-Cavanagh S, Lu C, Gayden T, Mikael LG, Bechet D, Karamboulas C, et al. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas. Nat Genet. 2017;49:180\u20135. https:\/\/doi.org\/10.1038\/ng.3757.","journal-title":"Nat Genet"},{"key":"4253_CR59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/00220345241297122","volume":"104","author":"Y Li","year":"2025","unstructured":"Li Y, Lu C. Targeting epigenetic dysregulations in head and neck squamous cell carcinoma. J Dent Res. 2025;104:225\u201334. https:\/\/doi.org\/10.1177\/00220345241297122.","journal-title":"J Dent Res"},{"key":"4253_CR60","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41587-022-01447-3","volume":"41","author":"V Fedyuk","year":"2023","unstructured":"Fedyuk V, Erez N, Furth N, Beresh O, Andreishcheva E, Shinde A, et al. Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics. Nat Biotechnol. 2023;41:212\u201321. https:\/\/doi.org\/10.1038\/s41587-022-01447-3.","journal-title":"Nat Biotechnol"},{"key":"4253_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101918","volume":"6","author":"N Erez","year":"2025","unstructured":"Erez N, Furth N, Fedyuk V, Wadden J, Aittaleb R, Adam T, et al. Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma. Cell Reports Medicine. 2025;6:101918. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101918.","journal-title":"Cell Reports Medicine"},{"key":"4253_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01271-x","volume":"15","author":"S Deng","year":"2022","unstructured":"Deng S, Feng Y, Pauklin S. 3D chromatin architecture and transcription regulation in cancer. J Hematol Oncol. 2022;15:49. https:\/\/doi.org\/10.1186\/s13045-022-01271-x.","journal-title":"J Hematol Oncol"},{"key":"4253_CR63","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.cell.2014.11.021","volume":"159","author":"SSP Rao","year":"2014","unstructured":"Rao SSP, Huntley MH, Durand NC, Stamenova EK, Bochkov ID, Robinson JT, et al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell. 2014;159:1665\u201380. https:\/\/doi.org\/10.1016\/j.cell.2014.11.021.","journal-title":"Cell"},{"key":"4253_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.molmed.2019.09.011","volume":"26","author":"OL Kantidze","year":"2020","unstructured":"Kantidze OL, Gurova KV, Studitsky VM, Razin SV. The 3D genome as a target for anticancer therapy. Trends Mol Med. 2020;26:141\u20139. https:\/\/doi.org\/10.1016\/j.molmed.2019.09.011.","journal-title":"Trends Mol Med"},{"key":"4253_CR65","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/ijc.30461","volume":"140","author":"C Sathitruangsak","year":"2017","unstructured":"Sathitruangsak C, Righolt CH, Klewes L, Tung Chang D, Kotb R, Mai S. Distinct and shared three-dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma. Int J Cancer. 2017;140:400\u201310. https:\/\/doi.org\/10.1002\/ijc.30461.","journal-title":"Int J Cancer"},{"key":"4253_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0768-0","volume":"16","author":"AR Barutcu","year":"2015","unstructured":"Barutcu AR, Lajoie BR, McCord RP, Tye CE, Hong D, Messier TL, et al. Chromatin interaction analysis reveals changes in small chromosome and telomere clustering between epithelial and breast cancer cells. Genome Biol. 2015;16:214. https:\/\/doi.org\/10.1186\/s13059-015-0768-0.","journal-title":"Genome Biol"},{"key":"4253_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02100-0","volume":"23","author":"Y Xue","year":"2024","unstructured":"Xue Y, Liu L, Zhang Y, He Y, Wang J, Ma Z, et al. Unraveling the key role of chromatin structure in cancer development through epigenetic landscape characterization of oral cancer. Mol Cancer. 2024;23:190. https:\/\/doi.org\/10.1186\/s12943-024-02100-0.","journal-title":"Mol Cancer"},{"key":"4253_CR68","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1158\/0008-5472.CAN-20-1287","volume":"80","author":"Y Liu","year":"2020","unstructured":"Liu Y, Guo B, Aguilera-Jimenez E, Chu VS, Zhou J, Wu Z, et al. Chromatin looping shapes KLF5-dependent transcriptional programs in human epithelial cancers. Cancer Res. 2020;80:5464\u201377. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1287.","journal-title":"Cancer Res"},{"key":"4253_CR69","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1101\/gr.201517.115","volume":"26","author":"PC Taberlay","year":"2016","unstructured":"Taberlay PC, Achinger-Kawecka J, Lun ATL, Buske FA, Sabir K, Gould CM, et al. Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations. Genome Res. 2016;26:719\u201331. https:\/\/doi.org\/10.1101\/gr.201517.115.","journal-title":"Genome Res"},{"key":"4253_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09469-3","volume":"10","author":"M Yang","year":"2019","unstructured":"Yang M, Vesterlund M, Siavelis I, Moura-Castro LH, Castor A, Fioretos T, et al. Proteogenomics and Hi-C reveal transcriptional dysregulation in high hyperdiploid childhood acute lymphoblastic leukemia. Nat Commun. 2019;10:1519. https:\/\/doi.org\/10.1038\/s41467-019-09469-3.","journal-title":"Nat Commun"},{"key":"4253_CR71","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.neo.2019.02.003","volume":"21","author":"R Braun","year":"2019","unstructured":"Braun R, Ronquist S, Wangsa D, Chen H, Anthuber L, Gemoll T, et al. Single chromosome aneuploidy induces genome-wide perturbation of nuclear organization and gene expression. Neoplasia. 2019;21:401\u201312. https:\/\/doi.org\/10.1016\/j.neo.2019.02.003.","journal-title":"Neoplasia"},{"key":"4253_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09500-7","volume":"10","author":"OL Kantidze","year":"2019","unstructured":"Kantidze OL, Luzhin AV, Nizovtseva EV, Safina A, Valieva ME, Golov AK, et al. The anti-cancer drugs curaxins target spatial genome organization. Nat Commun. 2019;10:1441. https:\/\/doi.org\/10.1038\/s41467-019-09500-7.","journal-title":"Nat Commun"},{"key":"4253_CR73","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314. https:\/\/doi.org\/10.1126\/science.123.3191.309.","journal-title":"Science"},{"key":"4253_CR74","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu PP, Sabatini DM. Cancer cell metabolism: warburg and beyond. Cell. 2008;134:703\u20137. https:\/\/doi.org\/10.1016\/j.cell.2008.08.021.","journal-title":"Cell"},{"key":"4253_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.599723","author":"S Rodr\u00edguez-Enr\u00edquez","year":"2020","unstructured":"Rodr\u00edguez-Enr\u00edquez S, Kaambre T, Moreno-S\u00e1nchez R. Editorial: metabolic plasticity of cancer. Front Oncol. 2020. https:\/\/doi.org\/10.3389\/fonc.2020.599723.","journal-title":"Front Oncol"},{"key":"4253_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00660","author":"A Klepinin","year":"2020","unstructured":"Klepinin A, Zhang S, Klepinina L, Rebane-Klemm E, Terzic A, Kaambre T, et al. Adenylate kinase and metabolic signaling in cancer cells. Front Oncol. 2020. https:\/\/doi.org\/10.3389\/fonc.2020.00660.","journal-title":"Front Oncol"},{"key":"4253_CR77","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020. https:\/\/doi.org\/10.1126\/science.aaw5473.","journal-title":"Science"},{"key":"4253_CR78","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-18-3527","volume":"79","author":"A Galan-Cobo","year":"2019","unstructured":"Galan-Cobo A, Sitthideatphaiboon P, Qu X, Poteete A, Pisegna MA, Tong P, et al. LKB1 and KEAP1\/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS -mutant lung adenocarcinoma. Cancer Res. 2019;79:3251\u201367. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3527.","journal-title":"Cancer Res"},{"key":"4253_CR79","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1081\/DMR-100102335","volume":"32","author":"PM Flatt","year":"2000","unstructured":"Flatt PM, Pietenpol JA. Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery*. Drug Metab Rev. 2000;32:283\u2013305. https:\/\/doi.org\/10.1081\/DMR-100102335.","journal-title":"Drug Metab Rev"},{"key":"4253_CR80","doi-asserted-by":"publisher","unstructured":"Ozbun MA, Butel JS. Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis. 1995. pp. 71\u2013141. https:\/\/doi.org\/10.1016\/S0065-230X(08)60252-3","DOI":"10.1016\/S0065-230X(08)60252-3"},{"key":"4253_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121682","volume":"17","author":"TA Grigoreva","year":"2024","unstructured":"Grigoreva TA, Romanova AA, Tribulovich VG, Pestov NB, Oganov RA, Kovaleva DK, et al. p53: The multifaceted roles of covalent modifications in cancer. Pharmaceuticals. 2024;17:1682. https:\/\/doi.org\/10.3390\/ph17121682.","journal-title":"Pharmaceuticals"},{"key":"4253_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165715","volume":"1866","author":"LC Leal-Esteban","year":"2020","unstructured":"Leal-Esteban LC, Fajas L. Cell cycle regulators in cancer cell metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2020;1866:165715. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165715.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"4253_CR83","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ceb.2012.10.015","volume":"24","author":"FJ Navarro","year":"2012","unstructured":"Navarro FJ, Weston L, Nurse P. Global control of cell growth in fission yeast and its coordination with the cell cycle. Curr Opin Cell Biol. 2012;24:833\u20137. https:\/\/doi.org\/10.1016\/j.ceb.2012.10.015.","journal-title":"Curr Opin Cell Biol"},{"key":"4253_CR84","doi-asserted-by":"publisher","unstructured":"Palmer N, Kaldis P. Regulation of the Embryonic Cell Cycle During Mammalian Preimplantation Development. 2016. pp. 1\u201353. https:\/\/doi.org\/10.1016\/bs.ctdb.2016.05.001","DOI":"10.1016\/bs.ctdb.2016.05.001"},{"key":"4253_CR85","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","volume":"5","author":"ZE Stine","year":"2015","unstructured":"Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CVMYC. Metabolism, and cancer. Cancer Discov. 2015;5:1024\u201339. https:\/\/doi.org\/10.1158\/2159-8290.CD-15-0507.","journal-title":"Cancer Discov"},{"key":"4253_CR86","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.08.053","volume":"154","author":"AC Lloyd","year":"2013","unstructured":"Lloyd AC. The regulation of cell size. Cell. 2013;154:1194\u2013205. https:\/\/doi.org\/10.1016\/j.cell.2013.08.053.","journal-title":"Cell"},{"key":"4253_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan K-L. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1\u201317. https:\/\/doi.org\/10.1101\/gad.274027.115.","journal-title":"Genes Dev"},{"key":"4253_CR88","doi-asserted-by":"publisher","unstructured":"Mitchison JM. Growth During the Cell Cycle. 2003. pp. 165\u2013258. https:\/\/doi.org\/10.1016\/S0074-7696(03)01004-0","DOI":"10.1016\/S0074-7696(03)01004-0"},{"key":"4253_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105330","volume":"299","author":"H Saunders","year":"2023","unstructured":"Saunders H, Dias WB, Slawson C. Growing and dividing: how O-GlcNAcylation leads the way. J Biol Chem. 2023;299:105330. https:\/\/doi.org\/10.1016\/j.jbc.2023.105330.","journal-title":"J Biol Chem"},{"key":"4253_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2016.00095","author":"P Kaldis","year":"2016","unstructured":"Kaldis P. Quo Vadis Cell Growth and Division? Front Cell Dev Biol. 2016. https:\/\/doi.org\/10.3389\/fcell.2016.00095. 4.","journal-title":"Front Cell Dev Biol"},{"key":"4253_CR91","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1248\/bpb.b17-00776","volume":"41","author":"B Shashni","year":"2018","unstructured":"Shashni B, Ariyasu S, Takeda R, Suzuki T, Shiina S, Akimoto K, et al. Size-based differentiation of cancer and normal cells by a particle size analyzer assisted by a cell-recognition PC software. Biol Pharm Bull. 2018;41:487\u2013503. https:\/\/doi.org\/10.1248\/bpb.b17-00776.","journal-title":"Biol Pharm Bull"},{"key":"4253_CR92","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add0636","author":"I Jones","year":"2023","unstructured":"Jones I, Dent L, Higo T, Roumeliotis T, Arias Garcia M, Shree H, et al. Characterization of proteome-size scaling by integrative omics reveals mechanisms of proliferation control in cancer. Sci Adv. 2023. https:\/\/doi.org\/10.1126\/sciadv.add0636.","journal-title":"Sci Adv"},{"key":"4253_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54182-5","volume":"15","author":"M Pizurica","year":"2024","unstructured":"Pizurica M, Zheng Y, Carrillo-Perez F, Noor H, Yao W, Wohlfart C, et al. Digital profiling of gene expression from histology images with linearized attention. Nat Commun. 2024;15:9886. https:\/\/doi.org\/10.1038\/s41467-024-54182-5.","journal-title":"Nat Commun"},{"key":"4253_CR94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2018.01.002","volume":"125","author":"S-J Hao","year":"2018","unstructured":"Hao S-J, Wan Y, Xia Y-Q, Zou X, Zheng S-Y. Size-based separation methods of circulating tumor cells. Adv Drug Deliv Rev. 2018;125:3\u201320. https:\/\/doi.org\/10.1016\/j.addr.2018.01.002.","journal-title":"Adv Drug Deliv Rev"},{"key":"4253_CR95","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.semcancer.2015.07.002","volume":"35","author":"Q Li","year":"2015","unstructured":"Li Q, Rycaj K, Chen X, Tang DG. Cancer stem cells and cell size: a causal link? Semin Cancer Biol. 2015;35:191\u20139. https:\/\/doi.org\/10.1016\/j.semcancer.2015.07.002.","journal-title":"Semin Cancer Biol"},{"key":"4253_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70024","author":"S Qian","year":"2024","unstructured":"Qian S, Long Y, Tan G, Li X, Xiang B, Tao Y, et al. Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets. MedComm. 2024. https:\/\/doi.org\/10.1002\/mco2.70024.","journal-title":"MedComm"},{"key":"4253_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30:87. https:\/\/doi.org\/10.1186\/1756-9966-30-87.","journal-title":"J Exp Clin Cancer Res"},{"key":"4253_CR98","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","volume":"24","author":"J Debnath","year":"2023","unstructured":"Debnath J, Gammoh N, Ryan KM. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24:560\u201375. https:\/\/doi.org\/10.1038\/s41580-023-00585-z.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4253_CR99","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1101\/gad.17558811","volume":"25","author":"AC Kimmelman","year":"2011","unstructured":"Kimmelman AC. The dynamic nature of autophagy in cancer. Genes Dev. 2011;25:1999\u20132010. https:\/\/doi.org\/10.1101\/gad.17558811.","journal-title":"Genes Dev"},{"key":"4253_CR100","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1083\/jcb.200703010","volume":"177","author":"M Curto","year":"2007","unstructured":"Curto M, Cole BK, Lallemand D, Liu C-H, McClatchey AI. Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin. J Cell Biol. 2007;177:893\u2013903. https:\/\/doi.org\/10.1083\/jcb.200703010.","journal-title":"J Cell Biol"},{"key":"4253_CR101","doi-asserted-by":"publisher","first-page":"6908","DOI":"10.1038\/onc.2008.342","volume":"27","author":"AF Hezel","year":"2008","unstructured":"Hezel AF, Bardeesy N. LKB1; linking cell structure and tumor suppression. Oncogene. 2008;27:6908\u201319. https:\/\/doi.org\/10.1038\/onc.2008.342.","journal-title":"Oncogene"},{"key":"4253_CR102","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1126\/science.1185837","volume":"328","author":"JD Shields","year":"2010","unstructured":"Shields JD, Kourtis IC, Tomei AA, Roberts JM, Swartz MA. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science. 2010;328:749\u201352. https:\/\/doi.org\/10.1126\/science.1185837.","journal-title":"Science"},{"key":"4253_CR103","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","volume":"31","author":"L Yang","year":"2010","unstructured":"Yang L, Pang Y, Moses HL. TGF-\u03b2 and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol. 2010;31:220\u20137. https:\/\/doi.org\/10.1016\/j.it.2010.04.002.","journal-title":"Trends Immunol"},{"key":"4253_CR104","doi-asserted-by":"publisher","unstructured":"Zahreddine H, Borden KLB. Mechanisms and insights into drug resistance in cancer. Front Pharmacol. 2013;4. https:\/\/doi.org\/10.3389\/fphar.2013.00028.","DOI":"10.3389\/fphar.2013.00028"},{"key":"4253_CR105","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrc1093","volume":"3","author":"G Bergers","year":"2003","unstructured":"Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer. 2003;3:401\u201310. https:\/\/doi.org\/10.1038\/nrc1093.","journal-title":"Nat Rev Cancer"},{"key":"4253_CR106","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/path.2801","volume":"223","author":"DX Nguyen","year":"2011","unstructured":"Nguyen DX. Tracing the origins of metastasis. J Pathol. 2011;223:196\u2013205. https:\/\/doi.org\/10.1002\/path.2801.","journal-title":"J Pathol"},{"key":"4253_CR107","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1126\/science.959840","volume":"194","author":"PC Nowell","year":"1976","unstructured":"Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194:23\u20138. https:\/\/doi.org\/10.1126\/science.959840.","journal-title":"Science"},{"key":"4253_CR108","first-page":"1355","volume":"50","author":"JS Wainscoat","year":"1990","unstructured":"Wainscoat JS, Fey MF. Assessment of clonality in human tumors: a review. Cancer Res. 1990;50:1355\u201360.","journal-title":"Cancer Res"},{"key":"4253_CR109","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883\u201392. https:\/\/doi.org\/10.1056\/NEJMoa1113205.","journal-title":"N Engl J Med"},{"key":"4253_CR110","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0188-4409(02)00450-2","volume":"34","author":"H Mayani","year":"2003","unstructured":"Mayani H. A glance into somatic stem cell biology. Arch Med Res. 2003;34:3\u201315. https:\/\/doi.org\/10.1016\/S0188-4409(02)00450-2.","journal-title":"Arch Med Res"},{"key":"4253_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1165-5","volume":"10","author":"W Zakrzewski","year":"2019","unstructured":"Zakrzewski W, Dobrzy\u0144ski M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10:68. https:\/\/doi.org\/10.1186\/s13287-019-1165-5.","journal-title":"Stem Cell Res Ther"},{"key":"4253_CR112","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020993","volume":"25","author":"G Velikic","year":"2024","unstructured":"Velikic G, Maric DM, Maric DL, Supic G, Puletic M, Dulic O, et al. Harnessing the stem cell niche in regenerative medicine: innovative avenue to combat neurodegenerative diseases. Int J Mol Sci. 2024;25:993. https:\/\/doi.org\/10.3390\/ijms25020993.","journal-title":"Int J Mol Sci"},{"key":"4253_CR113","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994;367:645\u20138. https:\/\/doi.org\/10.1038\/367645a0.","journal-title":"Nature"},{"key":"4253_CR114","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983\u20138. https:\/\/doi.org\/10.1073\/pnas.0530291100.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4253_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13402-016-0297-1","volume":"40","author":"A Chavez-Gonzalez","year":"2017","unstructured":"Chavez-Gonzalez A, Bakhshinejad B, Pakravan K, Guzman ML, Babashah S. Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer. Cell Oncol. 2017;40:1\u201320. https:\/\/doi.org\/10.1007\/s13402-016-0297-1.","journal-title":"Cell Oncol"},{"key":"4253_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu X, Tian W, Ning J, Xiao G, Zhou Y, Wang Z, et al. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct Target Ther. 2024;9:170. https:\/\/doi.org\/10.1038\/s41392-024-01851-y.","journal-title":"Signal Transduct Target Ther"},{"key":"4253_CR117","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1083\/jcb.201202014","volume":"198","author":"I Baccelli","year":"2012","unstructured":"Baccelli I, Trumpp A. The evolving concept of cancer and metastasis stem cells. J Cell Biol. 2012;198:281\u201393. https:\/\/doi.org\/10.1083\/jcb.201202014.","journal-title":"J Cell Biol"},{"key":"4253_CR118","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.arcmed.2022.11.012","volume":"53","author":"H Mayani","year":"2022","unstructured":"Mayani H, Ch\u00e1vez-Gonz\u00e1lez A, V\u00e1zquez-Santillan K, Contreras J, Guzman ML. Cancer Stem Cells: Biology and Therapeutic Implications. Arch Med Res. 2022;53:770\u201384. https:\/\/doi.org\/10.1016\/j.arcmed.2022.11.012.","journal-title":"Arch Med Res"},{"key":"4253_CR119","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1221175","author":"A Ordaz-Ramos","year":"2023","unstructured":"Ordaz-Ramos A, Tellez-Jimenez O, Vazquez-Santillan K. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. Front Cell Dev Biol. 2023. https:\/\/doi.org\/10.3389\/fcell.2023.1221175.","journal-title":"Front Cell Dev Biol"},{"key":"4253_CR120","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/s41388-022-02259-0","volume":"41","author":"Z Rong","year":"2022","unstructured":"Rong Z, Zhang L, Li Z, Xiao Z, Duan Y, Ren X, et al. SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt\/\u03b2-catenin signaling. Oncogene. 2022;41:2390\u2013403. https:\/\/doi.org\/10.1038\/s41388-022-02259-0.","journal-title":"Oncogene"},{"key":"4253_CR121","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/s41580-022-00568-6","volume":"24","author":"A de Morree","year":"2023","unstructured":"de Morree A, Rando TA. Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity. Nat Rev Mol Cell Biol. 2023;24:334\u201354. https:\/\/doi.org\/10.1038\/s41580-022-00568-6.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4253_CR122","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrg.2016.170","volume":"18","author":"R Schwartz","year":"2017","unstructured":"Schwartz R, Sch\u00e4ffer AA. The evolution of tumour phylogenetics: principles and practice. Nat Rev Genet. 2017;18:213\u201329. https:\/\/doi.org\/10.1038\/nrg.2016.170.","journal-title":"Nat Rev Genet"},{"key":"4253_CR123","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.trecan.2016.04.002","volume":"2","author":"RA Burrell","year":"2016","unstructured":"Burrell RA, Swanton C. Re-evaluating clonal dominance in cancer evolution. Trends Cancer. 2016;2:263\u201376. https:\/\/doi.org\/10.1016\/j.trecan.2016.04.002.","journal-title":"Trends Cancer"},{"key":"4253_CR124","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability \u2014 an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11:220\u20138. https:\/\/doi.org\/10.1038\/nrm2858.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4253_CR125","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41588-023-01592-8","volume":"56","author":"DR Caswell","year":"2024","unstructured":"Caswell DR, Gui P, Mayekar MK, Law EK, Pich O, Bailey C, et al. The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. Nat Genet. 2024;56:60\u201373. https:\/\/doi.org\/10.1038\/s41588-023-01592-8.","journal-title":"Nat Genet"},{"key":"4253_CR126","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.annonc.2020.03.303","volume":"31","author":"C Bailey","year":"2020","unstructured":"Bailey C, Shoura MJ, Mischel PS, Swanton C. Extrachromosomal DNA\u2014relieving heredity constraints, accelerating tumour evolution. Ann Oncol. 2020;31:884\u201393. https:\/\/doi.org\/10.1016\/j.annonc.2020.03.303.","journal-title":"Ann Oncol"},{"key":"4253_CR127","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41586-024-08107-3","volume":"635","author":"C Bailey","year":"2024","unstructured":"Bailey C, Pich O, Thol K, Watkins TBK, Luebeck J, Rowan A, et al. Origins and impact of extrachromosomal DNA. Nature. 2024;635:193\u2013200. https:\/\/doi.org\/10.1038\/s41586-024-08107-3.","journal-title":"Nature"},{"key":"4253_CR128","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nature10762","volume":"481","author":"M Greaves","year":"2012","unstructured":"Greaves M, Maley CC. Clonal evolution in cancer. Nature. 2012;481:306\u201313. https:\/\/doi.org\/10.1038\/nature10762.","journal-title":"Nature"},{"key":"4253_CR129","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010;463:899\u2013905. https:\/\/doi.org\/10.1038\/nature08822.","journal-title":"Nature"},{"key":"4253_CR130","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-genom-083117-021712","volume":"20","author":"MJ Williams","year":"2019","unstructured":"Williams MJ, Sottoriva A, Graham TA. Measuring clonal evolution in cancer with genomics. Annu Rev Genomics Hum Genet. 2019;20:309\u201329. https:\/\/doi.org\/10.1146\/annurev-genom-083117-021712.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"4253_CR131","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/ajh.27443","volume":"99","author":"E Jabbour","year":"2024","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring. Am J Hematol. 2024;99:2191\u2013212. https:\/\/doi.org\/10.1002\/ajh.27443.","journal-title":"Am J Hematol"},{"key":"4253_CR132","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108389","author":"R Vendramin","year":"2021","unstructured":"Vendramin R, Litchfield K, Swanton C. Cancer evolution: Darwin and beyond. EMBO J. 2021. https:\/\/doi.org\/10.15252\/embj.2021108389.","journal-title":"EMBO J"},{"key":"4253_CR133","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","volume":"144","author":"PJ Stephens","year":"2011","unstructured":"Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144:27\u201340. https:\/\/doi.org\/10.1016\/j.cell.2010.11.055.","journal-title":"Cell"},{"key":"4253_CR134","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/ng.3489","volume":"48","author":"MJ Williams","year":"2016","unstructured":"Williams MJ, Werner B, Barnes CP, Graham TA, Sottoriva A. Identification of neutral tumor evolution across cancer types. Nat Genet. 2016;48:238\u201344. https:\/\/doi.org\/10.1038\/ng.3489.","journal-title":"Nat Genet"},{"key":"4253_CR135","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/10590501.2014.907460","volume":"32","author":"B Ning","year":"2014","unstructured":"Ning B, Su Z, Mei N, Hong H, Deng H, Shi L, et al. Toxicogenomics and cancer susceptibility: advances with next-generation sequencing. Journal of Environmental Science and Health, Part C. 2014;32:121\u201358. https:\/\/doi.org\/10.1080\/10590501.2014.907460.","journal-title":"Journal of Environmental Science and Health, Part C"},{"key":"4253_CR136","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.mrrev.2008.05.004","volume":"659","author":"B PARSONS","year":"2008","unstructured":"PARSONS B. Many different tumor types have polyclonal tumor origin: evidence and implications. Mutat Res Rev Mutat Res. 2008;659:232\u201347. https:\/\/doi.org\/10.1016\/j.mrrev.2008.05.004.","journal-title":"Mutat Res Rev Mutat Res"},{"key":"4253_CR137","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1134\/S0006297917040022","volume":"82","author":"MK Ibragimova","year":"2017","unstructured":"Ibragimova MK, Tsyganov MM, Litviakov NV. Natural and chemotherapy-induced clonal evolution of tumors. Biochem Moscow. 2017;82:413\u201325. https:\/\/doi.org\/10.1134\/S0006297917040022.","journal-title":"Biochem Moscow"},{"key":"4253_CR138","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbcan.2009.11.002","volume":"1805","author":"A Marusyk","year":"2010","unstructured":"Marusyk A, Polyak K. Tumor heterogeneity: causes and consequences. Biochim et Biophys Acta (BBA) - Reviews Cancer. 2010;1805:105\u201317. https:\/\/doi.org\/10.1016\/j.bbcan.2009.11.002.","journal-title":"Biochim et Biophys Acta (BBA) - Reviews Cancer"},{"key":"4253_CR139","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/bjc.1965.96","volume":"19","author":"PJ Middleton","year":"1965","unstructured":"Middleton PJ. The histogenesis of mammary tumours induced in the rat by chemical carcinogens. Br J Cancer. 1965;19:830\u20139. https:\/\/doi.org\/10.1038\/bjc.1965.96.","journal-title":"Br J Cancer"},{"key":"4253_CR140","first-page":"2669","volume":"36","author":"N Lane","year":"1976","unstructured":"Lane N. The precursor tissue of ordinary large bowel cancer. Cancer Res. 1976;36:2669\u201372.","journal-title":"Cancer Res"},{"key":"4253_CR141","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56010015","volume":"56","author":"B Arneth","year":"2019","unstructured":"Arneth B. Tumor microenvironment. Medicina B Aires. 2019;56:15. https:\/\/doi.org\/10.3390\/medicina56010015.","journal-title":"Medicina B Aires"},{"key":"4253_CR142","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","volume":"18","author":"M Egeblad","year":"2010","unstructured":"Egeblad M, Nakasone ES, Werb Z. Tumors as Organs: complex tissues that interface with the entire organism. Dev Cell. 2010;18:884\u2013901. https:\/\/doi.org\/10.1016\/j.devcel.2010.05.012.","journal-title":"Dev Cell"},{"key":"4253_CR143","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6:392\u2013401. https:\/\/doi.org\/10.1038\/nrc1877.","journal-title":"Nat Rev Cancer"},{"key":"4253_CR144","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","volume":"139","author":"KR Levental","year":"2009","unstructured":"Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling. Cell. 2009;139:891\u2013906. https:\/\/doi.org\/10.1016\/j.cell.2009.10.027.","journal-title":"Cell"},{"key":"4253_CR145","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161\u201374. https:\/\/doi.org\/10.1038\/nrc745.","journal-title":"Nat Rev Cancer"},{"key":"4253_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-4-38","volume":"4","author":"PP Provenzano","year":"2006","unstructured":"Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 2006;4:38. https:\/\/doi.org\/10.1186\/1741-7015-4-38.","journal-title":"BMC Med"},{"key":"4253_CR147","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.devcel.2008.03.003","volume":"14","author":"AJ Ewald","year":"2008","unstructured":"Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell. 2008;14:570\u201381. https:\/\/doi.org\/10.1016\/j.devcel.2008.03.003.","journal-title":"Dev Cell"},{"key":"4253_CR148","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1182\/blood-2014-09-570192","volume":"125","author":"PE Boulais","year":"2015","unstructured":"Boulais PE, Frenette PS. Making sense of hematopoietic stem cell niches. Blood. 2015;125:2621\u20139. https:\/\/doi.org\/10.1182\/blood-2014-09-570192.","journal-title":"Blood"},{"key":"4253_CR149","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/jleuko\/qiad075","volume":"114","author":"D Hern\u00e1ndez-Barrientos","year":"2023","unstructured":"Hern\u00e1ndez-Barrientos D, Pelayo R, Mayani H. The hematopoietic microenvironment: a network of niches for the development of all blood cell lineages. J Leukoc Biol. 2023;114:404\u201320. https:\/\/doi.org\/10.1093\/jleuko\/qiad075.","journal-title":"J Leukoc Biol"},{"key":"4253_CR150","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341\u201352. https:\/\/doi.org\/10.1038\/s41580-020-0237-9.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4253_CR151","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/dvdy.20345","volume":"233","author":"ED Hay","year":"2005","unstructured":"Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 2005;233:706\u201320. https:\/\/doi.org\/10.1002\/dvdy.20345.","journal-title":"Dev Dyn"},{"key":"4253_CR152","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1172\/JCI36183","volume":"119","author":"M Zeisberg","year":"2009","unstructured":"Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119:1429\u201337. https:\/\/doi.org\/10.1172\/JCI36183.","journal-title":"J Clin Invest"},{"key":"4253_CR153","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0092-8674(03)00108-9","volume":"112","author":"M Perez-Moreno","year":"2003","unstructured":"Perez-Moreno M, Jamora C, Fuchs E. Sticky business. Cell. 2003;112:535\u201348. https:\/\/doi.org\/10.1016\/S0092-8674(03)00108-9.","journal-title":"Cell"},{"key":"4253_CR154","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nrc1276","volume":"4","author":"U Cavallaro","year":"2004","unstructured":"Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer. 2004;4:118\u201332. https:\/\/doi.org\/10.1038\/nrc1276.","journal-title":"Nat Rev Cancer"},{"key":"4253_CR155","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1172\/JCI23183","volume":"115","author":"RC Bates","year":"2005","unstructured":"Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, Kawakatsu H, et al. Transcriptional activation of integrin \u03b26 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest. 2005;115:339\u201347. https:\/\/doi.org\/10.1172\/JCI23183.","journal-title":"J Clin Invest"},{"key":"4253_CR156","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/ijc.24263","volume":"124","author":"Y Kuo","year":"2009","unstructured":"Kuo Y, Su C, Liu C, Chen T, Chen C, Wang H. Transforming growth factor-\u03b2 induces CD44 cleavage that promotes migration of MDA\u2010MB\u2010435s cells through the up\u2010regulation of membrane type 1\u2010matrix metalloproteinase. Int J Cancer. 2009;124:2568\u201376. https:\/\/doi.org\/10.1002\/ijc.24263.","journal-title":"Int J Cancer"},{"key":"4253_CR157","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1101\/gad.225334.113","volume":"27","author":"JH Tsai","year":"2013","unstructured":"Tsai JH, Yang J. Epithelial\u2013mesenchymal plasticity in carcinoma metastasis. Genes Dev. 2013;27:2192\u2013206. https:\/\/doi.org\/10.1101\/gad.225334.113.","journal-title":"Genes Dev"},{"key":"4253_CR158","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29:212\u201326. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001.","journal-title":"Trends Cell Biol"},{"key":"4253_CR159","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.4161\/cc.9.12.12050","volume":"9","author":"J Fuxe","year":"2010","unstructured":"Fuxe J, Vincent T, Garcia de Herreros A. Transcriptional crosstalk between TGF\u03b2 and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes. Cell Cycle. 2010;9:2363\u201374. https:\/\/doi.org\/10.4161\/cc.9.12.12050.","journal-title":"Cell Cycle"},{"key":"4253_CR160","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1158\/0008-5472.CAN-11-3123","volume":"72","author":"C-W Li","year":"2012","unstructured":"Li C-W, Xia W, Huo L, Lim S-O, Wu Y, Hsu JL, et al. Epithelial\u2013mesenchymal transition induced by TNF-\u03b1 requires NF-\u03baB\u2013mediated transcriptional upregulation of Twist1. Cancer Res. 2012;72:1290\u2013300. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3123.","journal-title":"Cancer Res"},{"key":"4253_CR161","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ncb1691","volume":"10","author":"M-H Yang","year":"2008","unstructured":"Yang M-H, Wu M-Z, Chiou S-H, Chen P-M, Chang S-Y, Liu C-J, et al. Direct regulation of TWIST by HIF-1\u03b1 promotes metastasis. Nat Cell Biol. 2008;10:295\u2013305. https:\/\/doi.org\/10.1038\/ncb1691.","journal-title":"Nat Cell Biol"},{"key":"4253_CR162","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1386-7","volume":"15","author":"H Polioudaki","year":"2015","unstructured":"Polioudaki H, Agelaki S, Chiotaki R, Politaki E, Mavroudis D, Matikas A, et al. Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer. BMC Cancer. 2015;15:399. https:\/\/doi.org\/10.1186\/s12885-015-1386-7.","journal-title":"BMC Cancer"},{"key":"4253_CR163","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/jclinpath-2012-201271","volume":"66","author":"CO Sung","year":"2013","unstructured":"Sung CO, Choi H, Lee K-W, Kim S-H. Sarcomatoid carcinoma represents a complete phenotype with various pathways of epithelial mesenchymal transition. J Clin Pathol. 2013;66:601\u20136. https:\/\/doi.org\/10.1136\/jclinpath-2012-201271.","journal-title":"J Clin Pathol"},{"key":"4253_CR164","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.stem.2014.02.002","volume":"14","author":"T Oskarsson","year":"2014","unstructured":"Oskarsson T, Batlle E, Massagu\u00e9 J. Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell. 2014;14:306\u201321. https:\/\/doi.org\/10.1016\/j.stem.2014.02.002.","journal-title":"Cell Stem Cell"},{"key":"4253_CR165","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1126\/science.1164853","volume":"321","author":"CA Klein","year":"2008","unstructured":"Klein CA. The metastasis cascade. Science (1979). 2008;321:1785\u20137. https:\/\/doi.org\/10.1126\/science.1164853.","journal-title":"Science (1979)"},{"key":"4253_CR166","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/ncb2048","volume":"12","author":"L Vermeulen","year":"2010","unstructured":"Vermeulen L, De Sousa E Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol. 2010;12:468\u201376. https:\/\/doi.org\/10.1038\/ncb2048.","journal-title":"Nat Cell Biol"},{"key":"4253_CR167","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ccr.2010.10.023","volume":"18","author":"J Anido","year":"2010","unstructured":"Anido J, S\u00e1ez-Border\u00edas A, Gonz\u00e0lez-Junc\u00e0 A, Rod\u00f3n L, Folch G, Carmona MA, et al. TGF-\u03b2 receptor inhibitors target the CD44high\/Id1high glioma-initiating cell population in human glioblastoma. Cancer Cell. 2010;18:655\u201368. https:\/\/doi.org\/10.1016\/j.ccr.2010.10.023.","journal-title":"Cancer Cell"},{"key":"4253_CR168","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc2618","volume":"9","author":"JA Joyce","year":"2009","unstructured":"Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9:239\u201352. https:\/\/doi.org\/10.1038\/nrc2618.","journal-title":"Nat Rev Cancer"},{"key":"4253_CR169","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrclinonc.2010.196","volume":"8","author":"N Takebe","year":"2011","unstructured":"Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol. 2011;8:97\u2013106. https:\/\/doi.org\/10.1038\/nrclinonc.2010.196.","journal-title":"Nat Rev Clin Oncol"},{"key":"4253_CR170","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158:1110\u201322. https:\/\/doi.org\/10.1016\/j.cell.2014.07.013.","journal-title":"Cell"},{"key":"4253_CR171","doi-asserted-by":"publisher","DOI":"10.1136\/bmjonc-2024-000437","volume":"3","author":"Y Yang","year":"2024","unstructured":"Yang Y, Huang G, Lian J, Long C, Zhao B, Liu X, et al. Circulating tumour cell clusters: isolation, biological significance and therapeutic implications. BMJ Oncol. 2024;3:e000437. https:\/\/doi.org\/10.1136\/bmjonc-2024-000437.","journal-title":"BMJ Oncol"},{"key":"4253_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25189-z","volume":"12","author":"R Taftaf","year":"2021","unstructured":"Taftaf R, Liu X, Singh S, Jia Y, Dashzeveg NK, Hoffmann AD, et al. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer. Nat Commun. 2021;12:4867. https:\/\/doi.org\/10.1038\/s41467-021-25189-z.","journal-title":"Nat Commun"},{"key":"4253_CR173","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1126\/science.1161621","volume":"321","author":"K Podsypanina","year":"2008","unstructured":"Podsypanina K, Du Y-C, Jechlinger M, Beverly LJ, Hambardzumyan D, Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science. 2008;321:1841\u20134. https:\/\/doi.org\/10.1126\/science.1161621.","journal-title":"Science"},{"key":"4253_CR174","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ccr.2007.12.003","volume":"13","author":"Y H\u00fcsemann","year":"2008","unstructured":"H\u00fcsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell. 2008;13:58\u201368. https:\/\/doi.org\/10.1016\/j.ccr.2007.12.003.","journal-title":"Cancer Cell"},{"key":"4253_CR175","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.gde.2009.12.002","volume":"20","author":"S Maheswaran","year":"2010","unstructured":"Maheswaran S, Haber DA. Circulating tumor cells: a window into cancer biology and metastasis. Curr Opin Genet Dev. 2010;20:96\u20139. https:\/\/doi.org\/10.1016\/j.gde.2009.12.002.","journal-title":"Curr Opin Genet Dev"},{"key":"4253_CR176","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2013.12.007","volume":"146","author":"AD Rhim","year":"2014","unstructured":"Rhim AD, Thege FI, Santana SM, Lannin TB, Saha TN, Tsai S, et al. Detection of Circulating Pancreas Epithelial Cells in Patients With Pancreatic Cystic Lesions. Gastroenterology. 2014;146:647\u201351. https:\/\/doi.org\/10.1053\/j.gastro.2013.12.007.","journal-title":"Gastroenterology"},{"key":"4253_CR177","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature20785","volume":"540","author":"H Hosseini","year":"2016","unstructured":"Hosseini H, Obradovi\u0107 MMS, Hoffmann M, Harper KL, Sosa MS, Werner-Klein M, et al. Early dissemination seeds metastasis in breast cancer. Nature. 2016;540:552\u20138. https:\/\/doi.org\/10.1038\/nature20785.","journal-title":"Nature"},{"key":"4253_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-018-0047-0","volume":"2","author":"W Chen","year":"2018","unstructured":"Chen W, Hoffmann AD, Liu H, Liu X. Organotropism: new insights into molecular mechanisms of breast cancer metastasis. NPJ Precis Oncol. 2018;2:4. https:\/\/doi.org\/10.1038\/s41698-018-0047-0.","journal-title":"NPJ Precis Oncol"},{"key":"4253_CR179","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329\u201335. https:\/\/doi.org\/10.1038\/nature15756.","journal-title":"Nature"},{"key":"4253_CR180","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1677481","author":"J Bautista","year":"2025","unstructured":"Bautista J, L\u00f3pez-Cort\u00e9s A. Deciphering organotropism reveals therapeutic targets in metastasis. Front Cell Dev Biol. 2025. https:\/\/doi.org\/10.3389\/fcell.2025.1677481.","journal-title":"Front Cell Dev Biol"},{"key":"4253_CR181","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cord\u00f3n-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3:537\u201349. https:\/\/doi.org\/10.1016\/S1535-6108(03)00132-6.","journal-title":"Cancer Cell"},{"key":"4253_CR182","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1172\/JCI22320","volume":"115","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005;115:44\u201355. https:\/\/doi.org\/10.1172\/JCI22320.","journal-title":"J Clin Invest"},{"key":"4253_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1602225","author":"L Liu","year":"2025","unstructured":"Liu L, Qu X, Wang Z, Ji C, Ling R, Yan C. Leaf-vein-inspired multi-organ microfluidic chip for modeling breast cancer CTC organotropism. Front Oncol. 2025. https:\/\/doi.org\/10.3389\/fonc.2025.1602225.","journal-title":"Front Oncol"},{"key":"4253_CR184","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/cncr.21778","volume":"106","author":"KR Hess","year":"2006","unstructured":"Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106:1624\u201333. https:\/\/doi.org\/10.1002\/cncr.21778.","journal-title":"Cancer"},{"key":"4253_CR185","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1073\/pnas.0712345105","volume":"105","author":"S Jones","year":"2008","unstructured":"Jones S, Chen W, Parmigiani G, Diehl F, Beerenwinkel N, Antal T, et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A. 2008;105:4283\u20138. https:\/\/doi.org\/10.1073\/pnas.0712345105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4253_CR186","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nature08021","volume":"459","author":"PD Bos","year":"2009","unstructured":"Bos PD, Zhang X-F, Nadal C, Shu W, Gomis RR, Nguyen DX, et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009;459:1005\u20139. https:\/\/doi.org\/10.1038\/nature08021.","journal-title":"Nature"},{"key":"4253_CR187","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1111\/j.1582-4934.2009.00764.x","volume":"13","author":"V Chabottaux","year":"2009","unstructured":"Chabottaux V, Ricaud S, Host L, Blacher S, Paye A, Thiry M, et al. Membrane-type 4 matrix metalloproteinase (MT4\u2010MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture. J Cell Mol Med. 2009;13:4002\u201313. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00764.x.","journal-title":"J Cell Mol Med"},{"key":"4253_CR188","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nature07445","volume":"456","author":"C Stockmann","year":"2008","unstructured":"Stockmann C, Doedens A, Weidemann A, Zhang N, Takeda N, Greenberg JI, et al. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature. 2008;456:814\u20138. https:\/\/doi.org\/10.1038\/nature07445.","journal-title":"Nature"},{"key":"4253_CR189","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000112848","volume":"188","author":"A von Holst","year":"2008","unstructured":"von Holst A. Tenascin C in stem cell niches: redundant, permissive or instructive? Cells Tissues Organs. 2008;188:170\u20137. https:\/\/doi.org\/10.1159\/000112848.","journal-title":"Cells Tissues Organs"},{"key":"4253_CR190","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.ccell.2024.08.015","volume":"42","author":"S Gan","year":"2024","unstructured":"Gan S, Macalinao DG, Shahoei SH, Tian L, Jin X, Basnet H, et al. Distinct tumor architectures and microenvironments for the initiation of breast cancer metastasis in the brain. Cancer Cell. 2024;42:1693-1712.e24. https:\/\/doi.org\/10.1016\/j.ccell.2024.08.015.","journal-title":"Cancer Cell"},{"key":"4253_CR191","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005857","volume":"4","author":"WS Carbonell","year":"2009","unstructured":"Carbonell WS, Ansorge O, Sibson N, Muschel R. The vascular basement membrane as \u201csoil\u201d in brain metastasis. PLoS One. 2009;4:e5857. https:\/\/doi.org\/10.1371\/journal.pone.0005857.","journal-title":"PLoS One"},{"key":"4253_CR192","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.trecan.2022.02.007","volume":"8","author":"J Almagro","year":"2022","unstructured":"Almagro J, Messal HA, Elosegui-Artola A, van Rheenen J, Behrens A. Tissue architecture in tumor initiation and progression. Trends Cancer. 2022;8:494\u2013505. https:\/\/doi.org\/10.1016\/j.trecan.2022.02.007.","journal-title":"Trends Cancer"},{"key":"4253_CR193","doi-asserted-by":"publisher","first-page":"570","DOI":"10.18632\/oncotarget.2677","volume":"6","author":"J Budczies","year":"2015","unstructured":"Budczies J, von Winterfeld M, Klauschen F, Bockmayr M, Lennerz JK, Denkert C, et al. The landscape of metastatic progression patterns across major human cancers. Oncotarget. 2015;6:570\u201383. https:\/\/doi.org\/10.18632\/oncotarget.2677.","journal-title":"Oncotarget"},{"key":"4253_CR194","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.7150\/jca.50317","volume":"12","author":"L Wu","year":"2021","unstructured":"Wu L, Zhu L, Xu K, Zhou S, Zhou Y, Zhang T, et al. Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data. J Cancer. 2021;12:1715\u201321. https:\/\/doi.org\/10.7150\/jca.50317.","journal-title":"J Cancer"},{"key":"4253_CR195","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00258","author":"B Yoo","year":"2018","unstructured":"Yoo B, Fuchs BC, Medarova Z. New directions in the study and treatment of metastatic cancer. Front Oncol. 2018. https:\/\/doi.org\/10.3389\/fonc.2018.00258.","journal-title":"Front Oncol"},{"key":"4253_CR196","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10522-006-9043-9","volume":"8","author":"M Ivankovi\u0107","year":"2007","unstructured":"Ivankovi\u0107 M, \u0106uku\u0161i\u0107 A, Goti\u0107 I, \u0160krobot N, Matija\u0161i\u0107 M, Polan\u010dec D, et al. Telomerase activity in HeLa cervical carcinoma cell line proliferation. Biogerontology. 2007;8:163\u201372. https:\/\/doi.org\/10.1007\/s10522-006-9043-9.","journal-title":"Biogerontology"},{"key":"4253_CR197","doi-asserted-by":"publisher","DOI":"10.1142\/S0218127415400131","volume":"25","author":"J Demongeot","year":"2015","unstructured":"Demongeot J, Demetrius LA. Complexity and stability in biological systems. Int J Bifurcation Chaos. 2015;25:1540013. https:\/\/doi.org\/10.1142\/S0218127415400131.","journal-title":"Int J Bifurcation Chaos"},{"key":"4253_CR198","doi-asserted-by":"publisher","first-page":"783","DOI":"10.4161\/cc.23720","volume":"12","author":"P Duesberg","year":"2013","unstructured":"Duesberg P, McCormack A. Immortality of cancers. Cell Cycle. 2013;12:783\u2013802. https:\/\/doi.org\/10.4161\/cc.23720.","journal-title":"Cell Cycle"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04253-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04253-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04253-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T03:11:58Z","timestamp":1779678718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04253-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":198,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4253"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04253-y","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval and consent to participate: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication: not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}